Citigroup
LABD icon

Citigroup’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Citigroup’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40
Closed -$2.9K – 5786
2024
Q4 		$2.9K Hold
40
– – ﹤0.01% 5525
2024
Q3 		$2.34K Hold
40
– – ﹤0.01% 5402
2024
Q2 		$2.93K Hold
40
– – ﹤0.01% 5305
2024
Q1 		$2.92K Hold
40
– – ﹤0.01% 5365
2023
Q4 		$3.88K Hold
40
– – ﹤0.01% 5365
2023
Q3 		$8.24K Hold
40
– – ﹤0.01% 4586
2023
Q2 		$5.75K Hold
40
– – ﹤0.01% 5168
2023
Q1 		$8.24K Hold
40
– – ﹤0.01% 4811
2022
Q4 		$6.9K Hold
40
– – ﹤0.01% 4962
2022
Q3 		$10K Sell
40
-84
-68% -$19.5K ﹤0.01% 4993
2022
Q2 		$48K Buy
124
+14
+13% +$7.02K ﹤0.01% 4555
2022
Q1 		$39K Sell
110
-30
-21% -$11.8K ﹤0.01% 4839
2021
Q4 		$36K Hold
140
– – ﹤0.01% 5212
2021
Q3 		$30K Hold
140
– – ﹤0.01% 5028
2021
Q2 		$27K Hold
140
– – ﹤0.01% 5140
2021
Q1 		$30K Buy
+140
New +$27.1K ﹤0.01% 5006
2020
Q3 		– Sell
-159
Closed -$103K – 7530
2020
Q2 		$110K Buy
159
+42
+36% +$52.8K ﹤0.01% 5501
2020
Q1 		$330K Buy
117
+116
+11,600% +$331K ﹤0.01% 4259
2019
Q4 		$2K Sell
1
-12
-92% -$42.6K ﹤0.01% 7553
2019
Q3 		$67K Buy
+13
New +$53.5K ﹤0.01% 5946
2019
Q2 		– Sell
-58
Closed -$244K – 7804
2019
Q1 		$211K Sell
58
-67
-54% -$325K ﹤0.01% 5047
2018
Q4 		$1.07M Sell
125
-12
-9% -$88K ﹤0.01% 3321
2018
Q3 		$668K Buy
137
+12
+10% +$57.9K ﹤0.01% 3929
2018
Q2 		$648K Sell
125
-13
-9% -$78.8K ﹤0.01% 3817
2018
Q1 		$1M Buy
138
+134
+3,350% +$931K ﹤0.01% 3231
2017
Q4 		$39K Sell
4
-571
-99% -$5.69M ﹤0.01% 6342
2017
Q3 		$5.29M Sell
575
-325
-36% -$3.92M ﹤0.01% 1714
2017
Q2 		$12.4M Buy
+900
New +$17.3M 0.01% 1007
2015
Q3 		– Sell
-35
Closed -$2.2M – 7544
2015
Q2 		$2.2M Buy
+35
New +$2.5M ﹤0.01% 2426

Other funds holding LABD

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
HT
Headlands Technologies Chicago, Illinois $878M AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citigroup's LABD Position: Q1 2025 in Review

Citigroup sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2025, closing a stake of 40 shares — an estimated $2.9K sold.

Citigroup first reported a position in LABD in Q2 2015 and held it in 29 quarters. The position peaked at $12.4M in Q2 2017. 14 funds tracked by Wall St. Rank hold LABD as of Q1 2025.

  • Citigroup reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2025 after selling out during the quarter.
  • Citigroup sold 40 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2025, an estimated $2.9K.
  • Citigroup first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2015 and held it in 29 quarters.
  • Citigroup's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $12.4M in Q2 2017.
  • 14 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2025.

Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.